Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus
Yuka Kawato, Hidehiko Fukahori, Koji Nakamura, Atsuo Kanno, Kaori Kubo, Masaki Hiramitsu, Toshihiro Matsuda, Yuichi Hanada, Takako Furukawa, Yutaka Nakajima, Fumitaka Kinugasa, Tatsuaki Morokata
Topics & Concepts
ImmunologyAutoantibodyAntigenAntigen presentationLupus nephritisSystemic lupus erythematosusMHC class IIMajor histocompatibility complexPathogenesisAutoimmune diseaseAutoimmunityBiologyMedicineT cellAntibodyImmune systemInternal medicineDiseaseSystemic Lupus Erythematosus ResearchT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research